-
同型半胱氨酸(homocysteine,Hcy)是甲硫氨酸脱甲基后形成的一种非必需含硫氨基酸,其本身并不参与蛋白质的合成[1]。人体从食物中获取的甲硫氨酸在甲硫氨酸腺苷转移酶的作用下与 ATP 结合形成S-腺苷甲硫氨酸,S-腺苷甲硫氨酸脱甲基后成为 S-腺 苷 同 型 半 胱 氨 酸(S-adenosyl-L-homocysteine, SAH),SAH在SAH水解酶的作用下分解为腺苷和Hcy。各种遗传性或获得性因素导致的血浆中的Hcy 水平超过正常值称为高同型半胱氨酸血症(hyperhomocysteinemia,HHcy)。HHcy可通过改变S-腺苷甲硫氨酸的含量影响DNA甲基化,进而参与表观遗传学的修饰和调控,是导致机体发生疾病的重要机制之一。大量研究结果表明,Hcy与心脑血管疾病、自身免疫性疾病、甲状腺疾病和肿瘤等表观遗传学相关疾病的发生发展密切相关[2-4]。本文就近年来Hcy与甲状腺疾病的研究进展进行综述。
同型半胱氨酸与甲状腺疾病关系的研究进展
Research progress on the relationship between homocysteine and thyroid diseases
-
摘要: 同型半胱氨酸(Hcy)是甲硫氨酸代谢过程的中间产物,以各种形式存在于血液中。自 20 世纪 30 年代发现Hcy以来,其在高血压、心脑血管疾病、免疫系统疾病和肿瘤疾病中的致病作用被越来越多的研究证实。近年来,Hcy与甲状腺疾病的关系也引起了研究者的广泛关注,其与多种甲状腺疾病的发生发展密切相关。笔者就Hcy与甲状腺功能亢进、甲状腺功能减退、慢性淋巴细胞性甲状腺炎和甲状腺癌等相关甲状腺疾病关系的研究进展进行综述。Abstract: Homocysteine (Hcy) is an intermediate product of methionine metabolism and exists in blood in various forms. The pathogenic effect of Hcy in hypertension, immune system, tumor, cardiovascular, and cerebrovascular diseases has been proven since the 1930s. The relationship between Hcy and thyroid diseases has attracted considerable attention from researchers in recent years due to its high correlation with the occurrence and development of various thyroid diseases. The author reviews the research progress of the relationship between Hcy and related thyroid diseases, such as hyperthyroidism, hypothyroidism, chronic lymphocytic thyroiditis, and thyroid cancer.
-
Key words:
- Hyperthyroidism /
- Hypothyroidism /
- Thyroid neoplasms /
- Homocysteine
-
[1] Catena C, Colussi G, Nait F, et al. Elevated Homocysteine Levels are Associated with the Metabolic Syndrome and Cardiovascular Events in Hypertensive Patients[J]. Am J Hypertens, 2015, 28(7): 943−950. DOI: 10.1093/ajh/hpu248. [2] Shah H, Jan MU, Altaf A, et al. Correlation of hyper-homocysteinemia with coronary artery disease in absence of conventional risk factors among young adults[J]. J Saudi Heart Assoc, 2018, 30(4): 305−310. DOI: 10.1016/j.jsha.2018.04.002. [3] Schaffer A, Verdoia M, Cassetti E, et al. Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study[J]. Thromb Res, 2014, 134(2): 288−293. DOI: 10.1016/j.thromres.2014.05.025. [4] Baszczuk A, Kopczyński Z. Hyperhomocysteinemia in patients with cardiovascular disease[J/OL]. Postepy Hig Med Dosw, 2014, 68: 579-589[2019-01-06]. https://phmd.pl/resources/html/article/details?id=55773&language=en. DOI: 10.5604/17322693.1102340. [5] Surmiak P, Baumert M, Walencka Z, et al. Homocysteine remethylation pathway in neonates with congenital heart disease and neural tube defects[J]. Ann Acad Med Siles, 2018, 72: 134−140. DOI: 10.18794/aams/77014. [6] 张汉卿, 闫福岭. 同型半胱氨酸水平与缺血性脑卒中的相关性研究[J]. 东南大学学报(医学版), 2019, 38(1): 77−80. DOI: 10.3969/j.issn.1671−6264.2019.01.016.
Zhang HQ, Yan FL. Relation of plasma homocysteine levels and ischemic stroke[J]. J Southeast Univ (Med Sci Edi), 2019, 38(1): 77−80. DOI: 10.3969/j.issn.1671−6264.2019.01.016.[7] Jiang B, Chen YM, Yao GE, et al. Effects of differences in serum total homocysteine, folate, and vitamin B12 on cognitive impairment in stroke patients[J/OL]. BMC Neurol, 2014, 14: 217[2019-01-06]. https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-014-0217-9. DOI: 10.1186/s12883-014-0217-9. [8] Colleran KM, Romero LA, Upton DA, et al. Methimazole-induced hypothyroidism paradoxically decreases homocysteine[J]. Metabolism, 2005, 54(4): 460−465. DOI: 10.1016/j.metabol.2004.10.013. [9] Orzechowska-Pawilojc A, Siekierska-Hellmann M, Syrenicz A, et al. Homocysteine, folate, and cobalamin levels in hyperthyroid women before and after treatment[J]. Endokrynol Pol, 2009, 60(6): 443−448. DOI: 10.1507/endocrj.K06−112. [10] Nedrebø BG, Hustad S, Schneede J, et al. Homocysteine and its relation to B-vitamins in Graves' disease before and after treatment: effect modification by smoking[J]. J Intern Med, 2003, 254(5): 504−512. DOI: 10.1046/j.1365−2796.2003.01222.x. [11] Zhou YD, Chen YF, Cao XQ, et al. Association between plasma homocysteine status and hypothyroidism: a meta-analysis[J/OL]. Int J Clin Exp Med, 2014, 7(11): 4544-4553[2019-01-06]. https://pubmed.ncbi.nlm.nih.gov/25550985/. [12] Avila MA, Berasain C, Prieto J, et al. Influence of Impaired Liver Methionine Metabolism on the Development of Vascular Disease and Inflammation[J]. Curr Med Chem Cardiovasc Hematol Agents, 2005, 3(3): 267−281. DOI: 10.2174/1568016054368197. [13] Ozkan Y, Dönder E, Güney H, et al. Changes in plasma homocysteine levels of rats with experimentally induced hypothyroidism and hyperthyroidism[J]. Neuro Endocrinol Lett, 2005, 26(5): 536−540. [14] Gołyński M, Lutnicki K, Krumrych W, et al. Relationship between Total Homocysteine, Folic Acid, and Thyroid Hormones in Hypothyroid Dogs[J]. J Vet Intern Med, 2017, 31(5): 1403−1405. DOI: 10.1111/jvim.14804. [15] Ziaee A, Tehrani NH, Hosseinkhani Z, et al. Effects of folic acid plus levothyroxine on serum homocysteine level in hypothyroidism[J]. Caspian J Intern Med, 2012, 3(2): 417−420. [16] Kutluturk F, Yuce S, Tasliyurt T, et al. Changes in metabolic and cardiovascular risk factors before and after treatment in overt hypothyroidism[J]. Med Glas, 2013, 10(2): 348−353. [17] Dong XJ, Yao Z, Hu YJ, et al. Potential harmful correlation between homocysteine and low-density lipoprotein cholesterol in patients with hypothyroidism[J]. Medicine, 2016, 95(29): e4291. DOI: 10.1097/MD.0000000000004291. [18] 陈燕勤. 甲状腺功能异常患者同型半胱氨酸和半胱氨酸蛋白酶抑制剂C水平检测的临床意义[J]. 中国卫生检验杂志, 2016, 26(7): 986−988.
Chen YQ. The clinical value of serum homocysteine and cystatin C levels for patients with thyroid dysfunction[J]. Chin J Health Lab Technol, 2016, 26(7): 986−988.[19] 韦怡春, 黄朝发, 李菊香. 同型半胱氨酸与心房颤动的研究进展[J]. 中华心血管病杂志, 2017, 45(6): 550−552. DOI: 10.3760/cma.j.issn.0253−3758.2017.06.021.
Wei YC, Huang ZF, Li JX. Research progress on the correlation between hmocysteine and atrial fibrilation[J]. Chin J Cardiol, 2017, 45(6): 550−552. DOI: 10.3760/cma.j.issn.0253−3758.2017.06.021.[20] Cicone F, Santaguida MG, My G, et al. Hyperhomocysteinemia in acute iatrogenic hypothyroidism: the relevance of thyroid autoimmunity[J]. J Endocrinol Invest, 2018, 41(7): 831−837. DOI: 10.1007/s40618−017−0811−y. [21] Lazzerini PE, Capecchi PL, Selvi E, et al. Hyperhomocysteinemia, inflammation and autoimmunity[J]. Autoimmun Rev, 2007, 6(7): 503−509. DOI: 10.1016/j.autrev.2007.03.008. [22] Wang YP, Lin HP, Chen HM, et al. Hemoglobin, iron, and vitamin B12 deficiencies and high blood homocysteine levels in patients with anti-thyroid autoantibodies[J]. J Formos Med Assoc, 2014, 113(3): 155−160. DOI: 10.1016/j.jfma.2012.04.003. [23] Carbotta G, Tartaglia F, Giuliani A, et al. Cardiovascular risk in chronic autoimmune thyroiditis and subclinical hypothyroidism patients. A cluster analysis[J]. Int J Cardiol, 2017, 230: 115−119. DOI: 10.1016/j.ijcard.2016.12.066. [24] 官娜, 吕秀波, 王丽红. 自身免疫性甲状腺炎经左旋甲状腺素干预后血清同型半胱氨酸表达水平[J]. 中国实验诊断学, 2015, 19(2): 228−229.
Guan N, Lyu XB, Wang LH. Level of serum homocysteine expression in autoimmune thyroiditis after intervention with levothyroxine[J]. Chin J Lab Diagn, 2015, 19(2): 228−229.[25] Ozdemir S, Silan F, Hasbek Z, et al. Increased T-Allele Frequency of 677 C>T Polymorphism in the Methylenetetrahydrofolate Reductase Gene in Differentiated Thyroid Carcinoma[J]. Genet Test Mol Biomarkers, 2012, 16(7): 780−784. DOI: 10.1089/gtmb.2011.0347. [26] Fard-Esfahani P, Fard-Esfahani A, Saidi P, et al. An increased risk of differentiated thyroid carcinoma in Iran with the 677C→T homozygous polymorphism in the MTHFR Gene[J]. Cancer Epidemiol, 2011, 35(1): 56−58. DOI: 10.1016/j.canep.2010.10.001. [27] 邱秀萍, 张志承. 同型半胱氨酸与甲状腺结节关系的临床分析[J]. 福建医药杂志, 2018, 40(2): 81−83.
Qiu XP, Zhang ZC. Clinical analysis of the relationship between homocysteine and thyroid nodules[J]. Fujian Med J, 2018, 40(2): 81−83.[28] Drewes YM, Poortvliet RKE, Blom JW, et al. Homocysteine Levels and Treatment Effect in the Prospective Study of Pravastatin in the Elderly at Risk[J]. J Am Geriatr Soc, 2014, 62(2): 213−221. DOI: 10.1111/jgs.12660. [29] Qin XH, Huo Y. H-Type hypertension, stroke and diabetes in China: Opportunities for primary prevention[J]. J Diabetes, 2016, 8(1): 38−40. DOI: 10.1111/1753−0407.12333. [30] 董塬. 高同型半胱氨酸血症与慢性肾脏病的相关性研究[J]. 中国实用医刊, 2017, 44(3): 5−8. DOI: 10.3760/cma.j.issn.1674−4756.2017.03.002.
Dong Y. Correlation study between hyperhomocystinemia and chronic kidney disease[J]. Chin J Pract Med, 2017, 44(3): 5−8. DOI: 10.3760/cma.j.issn.1674−4756.2017.03.002.
计量
- 文章访问数: 4487
- HTML全文浏览量: 3306
- PDF下载量: 19